vs
Side-by-side financial comparison of CENTURY CASINOS INC (CNTY) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $138.0M, roughly 1.2× CENTURY CASINOS INC). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 0.2%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs 0.7%).
Century Casinos, Inc. is a gambling company based in Colorado Springs, Colorado.
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
CNTY vs ESPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $138.0M | $168.4M |
| Net Profit | $-17.9M | — |
| Gross Margin | — | — |
| Operating Margin | 7.6% | 50.6% |
| Net Margin | -13.0% | — |
| Revenue YoY | 0.2% | 143.7% |
| Net Profit YoY | 80.1% | — |
| EPS (diluted) | $-0.62 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $138.0M | $168.4M | ||
| Q3 25 | $153.7M | $87.3M | ||
| Q2 25 | $150.8M | $82.4M | ||
| Q1 25 | $130.4M | $65.0M | ||
| Q4 24 | $137.8M | $69.1M | ||
| Q3 24 | $155.7M | $51.6M | ||
| Q2 24 | $146.4M | $73.8M | ||
| Q1 24 | $136.0M | $137.7M |
| Q4 25 | $-17.9M | — | ||
| Q3 25 | $-10.5M | $-31.3M | ||
| Q2 25 | $-12.3M | $-12.7M | ||
| Q1 25 | $-20.6M | $-40.5M | ||
| Q4 24 | $-90.3M | — | ||
| Q3 24 | $-8.1M | $-29.5M | ||
| Q2 24 | $-41.6M | $-61.9M | ||
| Q1 24 | $-13.5M | $61.0M |
| Q4 25 | 7.6% | 50.6% | ||
| Q3 25 | 11.1% | -11.4% | ||
| Q2 25 | 11.0% | 8.6% | ||
| Q1 25 | 5.5% | -34.0% | ||
| Q4 24 | -45.5% | -6.4% | ||
| Q3 24 | 11.5% | -31.0% | ||
| Q2 24 | 9.7% | 3.5% | ||
| Q1 24 | 6.1% | 52.5% |
| Q4 25 | -13.0% | — | ||
| Q3 25 | -6.9% | -35.9% | ||
| Q2 25 | -8.2% | -15.4% | ||
| Q1 25 | -15.8% | -62.2% | ||
| Q4 24 | -65.6% | — | ||
| Q3 24 | -5.2% | -57.2% | ||
| Q2 24 | -28.4% | -83.9% | ||
| Q1 24 | -10.0% | 44.3% |
| Q4 25 | $-0.62 | $0.32 | ||
| Q3 25 | $-0.35 | $-0.16 | ||
| Q2 25 | $-0.40 | $-0.06 | ||
| Q1 25 | $-0.67 | $-0.21 | ||
| Q4 24 | $-2.95 | $-0.14 | ||
| Q3 24 | $-0.26 | $-0.15 | ||
| Q2 24 | $-1.36 | $-0.33 | ||
| Q1 24 | $-0.45 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $68.9M | $167.9M |
| Total DebtLower is stronger | $328.9M | — |
| Stockholders' EquityBook value | $-97.7M | $-302.0M |
| Total Assets | $1.1B | $465.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $68.9M | $167.9M | ||
| Q3 25 | $77.7M | $92.4M | ||
| Q2 25 | $85.5M | $86.1M | ||
| Q1 25 | $84.7M | $114.6M | ||
| Q4 24 | $98.8M | $144.8M | ||
| Q3 24 | $118.8M | $144.7M | ||
| Q2 24 | $123.2M | $189.3M | ||
| Q1 24 | $136.5M | $226.6M |
| Q4 25 | $328.9M | — | ||
| Q3 25 | $329.3M | — | ||
| Q2 25 | $328.0M | — | ||
| Q1 25 | $328.8M | — | ||
| Q4 24 | $328.2M | — | ||
| Q3 24 | $327.5M | — | ||
| Q2 24 | $328.8M | — | ||
| Q1 24 | $328.5M | — |
| Q4 25 | $-97.7M | $-302.0M | ||
| Q3 25 | $-78.6M | $-451.4M | ||
| Q2 25 | $-66.9M | $-433.5M | ||
| Q1 25 | $-54.3M | $-426.2M | ||
| Q4 24 | $-34.7M | $-388.7M | ||
| Q3 24 | $56.8M | $-370.2M | ||
| Q2 24 | $64.6M | $-344.2M | ||
| Q1 24 | $106.1M | $-294.3M |
| Q4 25 | $1.1B | $465.9M | ||
| Q3 25 | $1.2B | $364.0M | ||
| Q2 25 | $1.2B | $347.1M | ||
| Q1 25 | $1.2B | $324.0M | ||
| Q4 24 | $1.2B | $343.8M | ||
| Q3 24 | $1.3B | $314.1M | ||
| Q2 24 | $1.3B | $352.3M | ||
| Q1 24 | $1.3B | $373.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.77× | — | ||
| Q2 24 | 5.09× | — | ||
| Q1 24 | 3.10× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-114.0K | $45.2M |
| Free Cash FlowOCF − Capex | $-4.7M | — |
| FCF MarginFCF / Revenue | -3.4% | — |
| Capex IntensityCapex / Revenue | 3.3% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-15.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-114.0K | $45.2M | ||
| Q3 25 | $144.0K | $-4.3M | ||
| Q2 25 | $11.3M | $-31.4M | ||
| Q1 25 | $-4.6M | $-22.6M | ||
| Q4 24 | $-2.3M | $-35.0M | ||
| Q3 24 | $7.4M | $-35.3M | ||
| Q2 24 | $3.0M | $-7.2M | ||
| Q1 24 | $-11.5M | $53.8M |
| Q4 25 | $-4.7M | — | ||
| Q3 25 | $-4.7M | — | ||
| Q2 25 | $5.5M | — | ||
| Q1 25 | $-11.3M | — | ||
| Q4 24 | $-16.9M | — | ||
| Q3 24 | $-2.8M | $-35.5M | ||
| Q2 24 | $-12.9M | $-7.3M | ||
| Q1 24 | $-29.9M | $53.8M |
| Q4 25 | -3.4% | — | ||
| Q3 25 | -3.1% | — | ||
| Q2 25 | 3.6% | — | ||
| Q1 25 | -8.7% | — | ||
| Q4 24 | -12.3% | — | ||
| Q3 24 | -1.8% | -68.7% | ||
| Q2 24 | -8.8% | -9.9% | ||
| Q1 24 | -22.0% | 39.0% |
| Q4 25 | 3.3% | 0.0% | ||
| Q3 25 | 3.2% | 0.0% | ||
| Q2 25 | 3.9% | 0.0% | ||
| Q1 25 | 5.1% | 0.0% | ||
| Q4 24 | 10.7% | 0.0% | ||
| Q3 24 | 6.6% | 0.3% | ||
| Q2 24 | 10.9% | 0.1% | ||
| Q1 24 | 13.5% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CNTY
| Gaming | $103.9M | 75% |
| Food And Beverage | $13.2M | 10% |
| Hotel | $10.5M | 8% |
| Other | $5.2M | 4% |
| Pari Mutuel And Sports Betting And Igaming | $5.2M | 4% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
